Fatigue is one of the most common long-term symptoms following COVID-19. A recent study in the Journal of Clinical Medicine explored whether ferritin, a protein that stores iron, might be linked to this persistent fatigue.
About the Study
Researchers studied 234 patients with long COVID symptoms and divided them into three groups:
-
Patients without fatigue
-
Patients with fatigue not meeting criteria for chronic fatigue syndrome (ME/CFS)
-
Patients with fatigue severe enough to meet ME/CFS criteria
Ferritin levels were measured to see if there was a relationship with fatigue severity.
Key Findings
-
Patients with ME/CFS-level fatigue after COVID-19 had higher ferritin levels than those with no or milder fatigue.
-
This trend was especially noticeable in women.
-
Higher ferritin levels were associated with more severe fatigue and lower quality of life scores.
What This Means
The study suggests that ferritin may play a role in the biological mechanisms behind severe fatigue after COVID-19. While higher ferritin does not prove it causes fatigue, it highlights a measurable difference in patients with long COVID fatigue.
Limitations
-
The study was conducted at a single hospital clinic, so results may not represent all populations.
-
It did not follow patients over time, so changes in ferritin levels and fatigue recovery remain unclear.
Conclusion
Ferritin levels appear to be linked with severe, persistent fatigue in people recovering from COVID-19, particularly in women. This research adds to the understanding that long COVID fatigue may have identifiable biological markers.
For the full study, see here
